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Abstract
Background: On the range of diagnoses, course of treatment, and long-term outcome in patients
who chose to receive homeopathic medical treatment very little is known. We investigated
homeopathic practice in an industrialized country under everyday conditions.
Methods:  In a prospective, multicentre cohort study with 103 primary care practices with
additional specialisation in homeopathy in Germany and Switzerland, data from all patients (age >1
year) consulting the physician for the first time were observed. The main outcome measures were:
Patient and physician assessments (numeric rating scales from 0 to 10) and quality of life at baseline,
and after 3, 12, and 24 months.
Results: A total of 3,981 patients were studied including 2,851 adults (29% men, mean age 42.5 ±
13.1 years; 71% women, 39.9 ± 12.4 years) and 1,130 children (52% boys, 6.5 ± 3.9 years; 48% girls,
7.0 ± 4.3 years). Ninety-seven percent of all diagnoses were chronic with an average duration of
8.8 ± 8 years. The most frequent diagnoses were allergic rhinitis in men, headache in women, and
atopic dermatitis in children. Disease severity decreased significantly (p < 0.001) between baseline
and 24 months (adults from 6.2 ± 1.7 to 3.0 ± 2.2; children from 6.1 ± 1.8 to 2.2 ± 1.9). Physicians'
assessments yielded similar results. For adults and young children, major improvements were
observed for quality of life, whereas no changes were seen in adolescents. Younger age and more
severe disease at baseline were factors predictive of better therapeutic success.
Conclusion:  Disease severity and quality of life demonstrated marked and sustained
improvements following homeopathic treatment period. Our findings indicate that homeopathic
medical therapy may play a beneficial role in the long-term care of patients with chronic diseases.
Background
Homeopathy is one of the most frequently used and con-
troversial systems of complementary and alternative med-
icine. It is based on the 'principle of similars', whereby
highly diluted preparations of substances that cause
symptoms in healthy individuals are used to stimulate
healing in patients who have similar symptoms when ill
[1]. When a single homeopathic remedy is selected based
on a patient's total symptom picture, it is called 'classical'
homeopathy [2]. According to a survey in the US [3], the
proportion of patients obtaining homeopathic care has
quadrupled in the last seven years. A survey in Britain [4]
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estimated that annual expenditures reached £34.04 mil-
lion (out-of-pocket £30.74 million, NHS £3.3 million).
For Germany, the country in which classical homeopathy
originated, a recent survey demonstrated that approxi-
mately 10% of men and 20% of women in the general
population used homeopathic medicines during the pre-
vious year [5]. General trends show a rise in the number
of individuals utilising naturopathic and homeopathic
therapeutic methods [6].
The General Medical Council in Germany grants an offi-
cial certification in homeopathy to physicians upon suc-
cessful completion of a three-year-long training
programme. Approximately 4,500 physicians in Germany
hold this additional certification [6]. However, with the
exception of some randomised, controlled trials including
patients with selected diagnoses [2,7] there is no data on
the health care offered by classical homeopathic medical
practices. Therefore, it is impossible to assess the state of
homeopathic health care and its effectiveness. We
designed this project with the goal of systematically col-
lecting data in the area of homeopathic health care for the
first time in Germany. The aim of the present study was to
determine the spectrum of diagnoses and treatments, as
well as the course of disease over time among patients
who chose to receive homeopathic treatment.
Methods
Patients were included consecutively in this prospective,
multi-centre observational study upon their first consulta-
tion with a participating physician and were followed up
for a total of 24 months. Evaluations were made using
standardised questionnaires. In order to provide as repre-
sentative a picture of homeopathic health care as possible,
patients were included in the study regardless of their
diagnosis. Patients were eligible for the study if they were
consulting the participating physician for the first time
and were at least 1 year of age. In order to participate in
the study, physicians were required to have passed certi-
fied training in classical homeopathy and at least three
years of experience in its practice. A total of 187 physicians
belonging to four different working groups were con-
tacted either by post or telephone and informed about the
study. Of these, 103 physicians chose to participate. Each
participating physician was trained in study procedures
and was subject to at least one monitoring visit during the
study period. All study participants provided written,
informed consent, and the study protocol was approved
by the appropriate ethics review boards.
Outcome measures
For patients, we developed different questionnaires for
three different age groups: 1–6 years of age, 7–16 years of
age, adults (>16 years of age). All questionnaires were
designed to document sociodemographic data, as well as
information on prior medical history, patient symptoms
and complaints, quality of life, and the use of any treat-
ment other than homeopathy. At baseline, patients
recorded the complaints that led them to consider home-
opathic treatment. Independently of their physicians,
patients rated the severity of their complaints on a
numeric rating scale (0 = no complaints, 10 = maximum
severity) [8]. All complaints listed by patients in their
baseline questionnaire were transferred to their follow-up
questionnaires by the study office personnel. This ensured
that each baseline complaint was assessed at each subse-
quent follow-up. For children between 1 and 6 years of
age, the KITA questionnaire [9] was used to assess general
health-related quality of life. It was completed by the chil-
dren's parents. Patients between 7 and 16 years of age
completed the KINDL questionnaire [10,11]. In addi-
tional, parents were asked to provide the required medical
information. For the adults, general health-related quality
of life was assessed using the MOS SF-36 questionnaire
[12]. The results of the SF-36 are presented in normalised
scores, the results being scaled in such a way that the nor-
mal German population has a mean score of 0 and a
standard deviation of 1.
The first questionnaire was distributed to the patients by
the study physician and completed prior to the start of
therapy (baseline). Patients sent their completed ques-
Patient selection Figure 1
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tionnaires to the study office in sealed envelopes. Follow-
up questionnaires were sent to all patients by the study
office at 3, 12, and 24 months.
For physicians, we developed a standardised question-
naire that allowed for continuous documentation during
the treatment/follow-up period (24 months), as well as
standardised points of assessment at 0, 3, 12 and 24
months. At each of these time points, the severity of a
maximum of 4 diagnoses and maximum of 8 symptoms
was rated by participating physicians using a numerical
rating scale [8]. This information was then forwarded to
the study office. The type of homeopathic treatment, the
use of any conventional therapy, as well as any referrals to
other physicians were recorded on a continuous basis.
Statistics
Data was double entered manually into an ACCESS© data-
base and subsequently compared using the SAS© system
followed by plausibility data checks if necessary. The diag-
noses, documented by study physicians, were encoded in
ICD-9 format and recorded by two specially trained study
staff members using DIACOS.© Statistical analysis was per-
formed using SAS/STAT© software (Version 8.2).
Data for adults (>16 years) and for children/adolescents
were analysed separately. In order to calculate the average
severity of the physicians' diagnoses, we took the four
diagnoses named first for each patient during the baseline
examination. For each of the follow-up assessment points
(i.e. at 3, 12, and 24 months) we ascertained the respec-
tive severity ratings made by study physicians.
All results reported here are based on the intention-to-
treat approach, i.e. each included patient entered the final
analyses. If patients dropped out or withdrew from the
study we replaced the respective missing values: baseline
complaints that had been cured were given a severity rat-
ing of 0 in all following examinations. For patients who
died during the study, we inserted the maximum severity
rating of 10. Other missing values were multiply imputed
following the suggestions of Rubin [13]. Instead of filling
in a single value as a substitute for a missing value, multi-
ple imputation is a strategy by which each missing value
is replaced simultaneously by a set of plausible values that
represents the uncertainty about the right value to impute.
Thus, the missing values are filled in several times gener-
ating several distinct data tables, each with a complete set
of data without any missing value. These complete data
tables are analyzed separately using appropriate statistical
models. Afterwards, the results from all statistical analyses
are pooled to generate treatment effects and p-values. In
our study we used the MCMC (Marcov chain Monte
Carlo) replacement method and created 5 multiple
imputed data tables.
For each imputed data set, treatment effects were esti-
mated on the basis of generalized linear regression mod-
els. Generalized linear regression models are flexible and
powerful tools to describe data from cohort studies [14].
They are generalizations of the well known and often
applied multiple regression models which often appear to
be too simple to describe longitudinal data adequately. A
generalized linear model is best described by two compo-
nents. First, the mean course of the outcome, and second,
the correlation structure for measurements taken at the
same individual at different times. In our study we divided
the 2-year follow-up period into two parts. During the first
part (months 0–3) we assumed that mean outcome
increases (or decreases) linearly. For the second part
(months 3–21) we assumed that the mean outcome
increases (or decreases) according to a quadratic term.
Moreover, we assumed that the correlation between two
measurements can be described by a simple exponential
function. This essentially means, that the correlation only
depends from the time span between the two measure-
ments, and it decreases the bigger this time span is. This
approach is completely analogous to the recommenda-
tions given by Diggle, Liang, and Zeeger in their standard
text book on the analysis of longitudinal data [14].
Subgroup analyses are based on essentially the same sta-
tistical approach adding the respective factors as a fixed
covariate into the models. For subgroup analyses adults'
and children's data were pooled.
Usually, patients for clinical studies are not selected ran-
domly from a target population but according to some
selection criteria that sample patients according to
extreme measurements (high blood pressure, severe pain,
low quality of life, ...). This inevitably leads to regression-
to-the-mean, a statistical phenomenon that makes natural
variation look like real changes [15]. Separating regres-
sion-to-the-mean effects from true treatment effects can
be difficult but is at least feasible when the mean and the
standard deviation of the target population are known. In
this situation it is possible to calculate the expected out-
come for each patient when regression-to-the-mean
Table 1: Baseline characteristics of study population
Adults Children
Gender (% female) 70.8 48.3
Age (years, mean ± std) 40.7 ± 12.7 6.7 ± 4.1
Marital status (% living in partnership) 84.0 /
Education (% attending school >10 years) 85.0 /
Belief in homeopathy (%) 65.7 68.6†
Duration of disease (years, mean ± std) 10.3 ± 9.8 4.3 ± 3.7
Intake of conventional drugs (%) 50.2 31.7
† Parents' perspectiveBMC Public Health 2005, 5:115 http://www.biomedcentral.com/1471-2458/5/115
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occurs [16]. In our study we made a rather conservative
assumption on the target population (chronically ill
patients seeking homeopathic care): to have the same
quality of life as the general German population (i.e. a
mean SF-36 score of 0 and a standard deviation of 1).
From this we calculated the expected regression-to-the
mean effect and compared it to the actually observed
change of the SF-36 scores.
Results
A total of 103 physicians participated in the study (51
male, 45 ± 7 years of age; 52 female, 45 ± 7 years of age).
Twenty-six percent of the participating physicians were
specialists (10% internists, 9% paediatricians, 7% other)
and 74% were general practitioners. The average duration
of overall medical practice was 17.4 ± 8.4 years with 9.0 ±
4.4 years of practice in homeopathy (range 3–20 years).
Forty percent of the physicians were certified to work in
the public health care system, and 60% were in private
practice.
Patients were recruited for the study between September
1997 and December 1999. Of the patients who met the
inclusion criteria, 3981 (68%) chose to participate and
were included in the study (for patient selection see Figure
1). Of these, 2851 were adults (71% women) and 1130
were children (48% girls). The baseline characteristics are
listed in Table 1.
On average, the homeopathic physicians made 2.6 ± 1.2
diagnoses per patient (2.8 ± 1.1 in adults, 2.3 ± 1.1 in chil-
dren). Ninety-seven percent of all diagnoses were classi-
fied by these physicians as chronic with a median
duration of 4.3 ± 2.7 years in children and 10.3 ± 9.8 years
in adults. Almost all patients had received conventional
treatment (95%) or had already contacted another physi-
cian (95%) prior to the start of this study. The most com-
mon diagnosis in women was migraine (9.7%), in men
allergic rhinitis (10.3%), and in children of both genders
atopic dermatitis (20%), for details see [17]. For the most
common disease groups see Figure 2.
All patients underwent an initial homeopathic anamnesis,
lasting an average of 2.0 ± 0.7 hours. Following enrolment
in the study, patients had to wait an average of 57 ± 84
days before undergoing the initial anamnesis. During the
24-month observation period, patients consulted their
physicians an average of 7.8 ± 8.4 times. During the study
period, half of the patients (50.3%, adults: 50.8%, chil-
dren 48.9%) noted additional visits to non-study physi-
cians (gynaecologists and dentists excluded). The intake
of conventional medication decreased from 45.0% at
Most common medical complaints as reported by the homeopathy physicians (in % of documented complaints) Figure 2
Most common medical complaints as reported by the homeopathy physicians (in % of documented complaints).BMC Public Health 2005, 5:115 http://www.biomedcentral.com/1471-2458/5/115
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baseline (adults: 50.2%, children 31.7%) to 26.8% after
24 months (adults: 31.8%, children 14.2%).
According to patient assessments, disease severity
decreased significantly between baseline and 12 months,
as well as between 12 months and 24 months (see Table
2). According to physician assessments, 25.7% (adults:
21.9%, children: 37.6%) of the diagnoses were no longer
present at 24 months, whereas patients judged 23.0%
(adults 19.7%, children 32.8%) of the medical com-
plaints to have resolved by this point. Thirteen percent of
the patients documented that they had no complaints
whatsoever at 24 months.
In adults, large improvements in quality of life were
observed on both component scales (mental and physi-
cal) during the first three months of treatment, and con-
tinued to improve during the course of the study (see
Table 2). Even with the pessimistic assumption that the
test-retest correlation of the SF-36 is only 0.7 and that the
study population is no more ill than a random sample of
the general population, one could expect an improvement
of only 3.8 (1.2) score points on the mental (physical)
component scale, attributable to regression-to-the-mean
[16], markedly lower than the 5.6 (2.6) score points
observed in our study (Table 2). Statistically, the baseline
quality of life of non-completers was not significantly
lower than in other patients (p-values: MCS: p = 0.37;
PCS: p = 0.48, Wilcoxon-tests).
Quality of life in young children (age 1–6 years) also
improved markedly during the observation period (Table
2), having already risen during the first three months of
study therapy as measured on both scales of the KITA
questionnaire (mental-physical dimension and aspects of
daily living, each p < 0.001, see Table 2). These improve-
ments continued over the course of treatment (p < 0.001,
see Table 2). In school children and adolescents, however,
an improvement in quality of life was only visible during
the first three months of study therapy (p < 0.001, see
Table 2).
The diagnosis had no relevant influence on the changes in
patient complaints or quality of life as measured in this
investigation.
In patient and physician assessments, younger patients
showed greater improvements than did older patients and
more severe disease at baseline was followed by greater
improvements compared to less severe disease (see Table
3). Gender, duration of disease and belief in homeopathy
had only a minor influence on improvements.
Discussion
Patient and physician assessments of disease severity and
quality of life consistently demonstrated substantial
improvements following homeopathic treatment, which
were maintained through 24 months' follow up. Improve-
ments were more pronounced in younger patients and in
Table 2: Course of outcome parameters and estimated mean changes of outcome parameters
Estimated changes compared to baseline†
Baseline 3 months 12 months 24 month ∆ 3 months ∆ 12 months ∆ 24 months




6.2 ± 1.7 3.8 ± 2.2* 3.3 ± 2.1* 2.9 ± 2.2* -2.4 (-2.5 to -2.3) -2.8 (-2.9 to -2.7) -3.1 (-3.2 to -3.0)
Physicians assessments 
(NRS) ‡
6.0 ± 1.6 3.9 ± 2.1* 2.8 ± 2.1* 2.1 ± 2.0* -2.1 (-2.2 to -2.0) -3.1 (-3.2 to -3.0) -3.7 (-3.8 to -3.6)
SF-36 QoL physical scale 46.5 ± 10.1 49.1 ± 9.5* 50.1 ± 9.6* 50.7 ± 9.5* 2.6 (2.3 to 2.9) 3.5 (3.0 to 3.9) 4.1 (3.5 to 4.6)




6.1 ± 1.8 3.2 ± 2.3* 2.5 ± 2.1* 2.2 ± 2.0* -3.1 (-3.3 to -2.9) -3.5 (-3.7 to -3.4) -3.9 (-4.0 to -3.7)
Physicians assessments 
(NRS) ‡
5.9 ± 1.7 3.2 ± 2.2* 2.0 ± 1.5* 1.5 ± 1.8* -2.7 (-2.8 to -2.6) -3.8 (-4.0 to -3.7) -4.4 (-4.6 to -4.3)
KINDL QoL 69.3 ± 13.3 72.1 ± 12.6 68.0 ± 9.2 67.3 ± 9.9* 2.7 (1.7 to 3.7) -0.4 (-1.5 to 0.8) -2.2 (-3.6 to -0.8)
KITA QoL mental/
physical dimension
67.6 ± 16.9 75.4 ± 14.6* 77.0 ± 14.1* 77.5 ± 14.3* 8.3 (6.6 to 10.0) 9.3 (7.7 to 10.8) 10.0 (8.3 to 11.6)
KITA QoL aspects of daily 
living
58.6 ± 18.3 66.9 ± 15.9* 69.1 ± 16.7* 70.6 ± 16.0* 8.5 (7.2 to 9.8) 10.4 (8.8 to 12.0) 11.6 (9.7 to 13.5)
† estimations are based on generalised linear models, see text; ‡ = lower values indicate better status and negative ∆ indicates improvement
QoL = quality of life; NRS = numeric rating scale, * p < 0.001 versus baselineBMC Public Health 2005, 5:115 http://www.biomedcentral.com/1471-2458/5/115
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those with greater disease severity compared to older
patients and those with less severe disease at baseline.
To our knowledge, the present study is the first to evaluate
systematically the range of diagnoses and therapies in
classical homeopathic medical practices in Germany and
Switzerland. In addition, the study provided information
on the course of illness in patients receiving homeopathic
treatment, as assessed by patients and physicians.
The methodological strengths of our study include con-
secutive enrolment of a large sample size, the participa-
tion of approximately 2% of all physicians certified to
practice homeopathy in Germany and 28% of all mem-
bers of the Hahnemann Association (an organisation for
physicians practicing only 'classical' homeopathy) and
the use of standardised outcome instruments also used in
studies on conventional therapy.
One limitation of our study is that the observed effects
cannot be categorized with respect to specificity, i.e. we
cannot draw conclusions as to the beneficial mechanisms.
Furthermore patients were allowed to use conventional
therapies during the study period in addition to homeo-
pathic treatment. Thus, the observed improvement can-
not be attributed to homeopathic treatment alone. The
aim of the investigation, however, was not to test the
effectiveness of homeopathic treatment alone, but rather
provide systematic and detailed information about the
current status of homeopathic medical care in routine
practice and its effectiveness. These data may also be help-
ful in the planning of further research projects on home-
opathy.
The effects observed by patient and the physician assess-
ment, as well as those seen with regard to quality of life,
deserve additional comments. The average severity of the
Table 3: Subgroup analyses for patients and physicians assessments (mean changes of outcome parameters after 24 months compared 
to baseline, negative ∆ indicates improvement)
Patients assessments (NRS) Physicians assessments (NRS)
Mean† 95%-CI p value* Mean† 95%-CI p value*
Total (n = 3981) -3.3 -3.4 to -3.2 -3.9 -4.0 to -3.8 0,060
Gender
Female (n = 
2560)
-3.4 -3.5 to -3.2 -3.9 -4.0 to -3.8
Male (n = 1412) -3.3 -3.4 to -3.1 0.387 -3.9 -4.0 to -3.8 0,060
Age groups (years)
<10 (n = 839) -4.0 -4.2 to -3.8 -4.4 -4.6 to -4.2
10–19 (n = 
355)
-3.5 -3.7 to -3.2 <0.001 -4.3 -4.5 to -4.0 0.149
20–39 (n = 
1456)
-3.4 -3.6 to -3.3 <0.001 -3.7 -3.8 to -3.6 <0.001
40–59 (n = 
1041)
-2.8 -3.8 to -2.0 <0.001 -3.6 -3.8 to -3.5 <0.001
≥ 60 (n = 281) -2.6 -2.9 to -2.2 <0.001 -3.5 -3.8 to -3.2 <0.001
Baseline severity of disease
NRS < 6.0 (n = 
1660)
-2.1 -2.3 to -2.0 -3.1 -3.2 to -3.0
NRS ≥ 6.0 (n = 
2310)
-4.1 -4.2 to -4.0 <0.001 -4.6 -4.7 to -4.5 <0.001
Duration of disease in adults (years)
< 10 (n = 1878) -3.2 -3.4 to -3.1 -3.7 -3.8 to -3.6
≥ 10 (n = 927) -2.9 -3.1 to -2.7 <0.001 -3.6 -3.7 to -3.4 0.043
Intake of conventional drugs at baseline
Yes (n = 1788) -3.3 -3.5 to -3.2 -3.8 -3.9 to -3.7
No (n = 2188) -3.3 -3.5 to -3.2 0.157 -3.9 -4.0 to -3.9 0.029
Belief in homeopathy
Strong (n = 
2656)
-3.4 -3.5 to -3.1 -3.9 -4.0 to -3.8
Weak (n = 
1316)
-3.1 -3.3 to -3.0 <0.001 -3.8 -3.9 to -3.7 0.563
† estimations are based on generalised linear models, NRS = numeric rating scale; * per item each subgroup compared to the first listed subgroupBMC Public Health 2005, 5:115 http://www.biomedcentral.com/1471-2458/5/115
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chronic diseases was reduced by approximately 50% after
only 3 months of homeopathic treatment, and remained
around this level during the follow-up period. Physician
assessments tended to be more positive than patient
assessments.
The improvements we observed in our patients cannot be
attributed solely to regression-to-the-mean, because the
improvements were greater than could be expected even
under conservative model assumptions. This is supported
by the fact that patients did not visit the study physicians
when they were feeling the worst, but rather after a long
waiting period.
A strength of this study is that patients with all diagnoses
were included. Therefore, no disease-specific measure-
ment instruments could be used. To assess the severity of
different medical complaints, there is no other generally
accepted measuring instrument available. Instead numer-
ical rating scales [8] were applied, which would allow for
the determination of illness severity in a diagnosis-inde-
pendent manner.
Compared to the other quality two of life questionnaires
used in our study, the KINDL questionnaire for the age
group 7 to 16 years was not sensitive to change, as has
been shown in other studies [18,19]. Other explanations
might be that children adapt easier to perceived quality of
life and that the dimensions of Quality of life used for
adults are not transferable to children. However, there is
no other generally accepted measuring instrument availa-
ble in German-speaking countries.
In the range of baseline diagnoses, chronic illnesses
clearly predominated (>95% of diagnoses). Among these,
headache and atopic disease (allergic rhinitis, asthma and
atopic dermatitis) were the most common diagnoses. As
the clinical histories of our patients showed, most of our
patients decided to consult a homeopathic physician only
after having received conventional treatment. This,
together with the extensive initial case taking and the rep-
utation of homeopathy as a "medicine designed to treat
the individual as a whole"' causes a selection for chronic
illnesses.
We were unable to confirm the common notion that
homeopathy is frequently used for trivial complaints or
diseases. The duration of disease in study patients was
very long and their symptoms were, on average, of mod-
erate severity.
In this study we were not able to evaluate different types
of homeopathic strategies. For quality assurance pur-
poses, we avoided selecting a random sample of homeo-
pathic physicians for the study, choosing instead to recruit
physicians schooled and certified in 'classical' homeopa-
thy. The results of our study are, therefore, representative
only for the classical type of homeopathy that was prac-
tised by participating physicians. Compared to conven-
tional medical practices, headache and atopic disease
(allergic rhinitis, asthma and atopic dermatitis) were the
most common diagnoses in homeopathic practices (as
opposed to hypertension, hyperlipidemia and low back
pain in 70,000 patients treated conventionally) [9]. An
American study [20] found asthma, depression, otitis
media, and allergic rhinitis to be the most common diag-
noses treated in homeopathic practices, compared to
hypertension, upper respiratory tract infection, otitis
media and diabetes mellitus, which were treated most
commonly in conventional practices.
A health insurance company project that included about
900 patients treated with homeopathy in routine care [21]
showed an improvement in quality of life and in physi-
cian assessment. In Güthlin's study [21], however, only
physicians certified to work in the public health care sys-
tem were able participate. Homeopaths working in private
practices (i.e. the great majority in Germany) were
excluded. The advantage of the present study is that doc-
tors in private practice were also included, thus providing
a more detailed and broader basis for describing the cur-
rent status of homeopathic health care. Another control-
led study in cooperation with a German health insurance
company [22], indicated similar overall effectiveness of
homeopathically versus conventionally treated patients
for selected diagnoses and in some groups, superiority of
homeopathic treatment.
Conclusion
We evaluated for the first time the range of diagnoses and
therapies at medical practices offering classical homeo-
pathic treatment in Germany and Switzerland. The find-
ings of our study demonstrate that patients who seek
homeopathic treatment are primarily those suffering from
long-standing, chronic disease. Both according to physi-
cian and patient assessments, the severity of complaints
decreased markedly over the 24-month observation
period. Younger patients and those with more severe dis-
ease appear to benefit most from homeopathic treatment.
Among adults and children, we observed an increase in
quality of life. Our findings indicate that homeopathic
medical therapy may play a beneficial role in the long-
term care of patients with chronic diseases.
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